GL1X · GenesisL1 explorer

UniProt O60260

E3 ubiquitin-protein ligase parkin (O60260)

E3 ubiquitin-protein ligase parkin (UniProt O60260), EC 2.3.2.-, 2.3.2.31: 34 experimental structures and 1 predicted model on GenesisL1, 5 ligands bound, 68 pockets. Binding sites, druggability and experiment against prediction…

UniProt
O60260
Protein
E3 ubiquitin-protein ligase parkin
EC
2.3.2.-, 2.3.2.31, 6.3.2.-, 6.3.2.19
Experimental structures
34
Predicted models
1
Ligands
5
Pockets
68 · 11 records with a druggable one

Structures

35 records of O60260 in the MolNFT archive: 34 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1IYFSolution structure of ubiquitin-like domain of human parkinsolution nmrA——
1IYFSolution structure of ubiquitin-like domain of human parkinsolution nmrA——
2JMOIBR domain of Human Parkinsolution nmrA——
2JMOIbr domain of human parkinsolution nmrA——
4BM9Structure of the autoinhibited Parkin catalytic domainx-ray diffractionA——
4BM9Structure of the autoinhibited parkin catalytic domainx-ray diffractionA——
4I1FStructure of Parkin-S223P E3 ligasex-ray diffractionA——
4I1FStructure of parkin-S223P E3 ligasex-ray diffractionA——
4I1HStructure of Parkin E3 ligasex-ray diffractionA——
4I1HStructure of parkin E3 ligasex-ray diffractionA——
5C1ZParkin (UBLR0RBR)x-ray diffractionA, B——
5C23Parkin (S65DUblR0RBR)x-ray diffractionA, BZN, SO4, CL14 (best 0.67)
5C23Parkin (S65DUBLR0RBR)x-ray diffractionA, B——
5C9VStructure of human Parkin G319Ax-ray diffractionAZN, SO43 (best 0.44)
5C9VStructure of human parkin G319Ax-ray diffractionA——
5N2WWT-Parkin and pUB complexx-ray diffractionAZN, CL, TMO—
5N2WWt-parkin and pub complexx-ray diffractionA3CN, ZN, CL, TMO—
5N38S65DParkin and pUB complexx-ray diffractionACL, ZN5 (best 0.73)
5N38S65DPARKIN and pub complexx-ray diffractionA3CN, CL, ZN—
5TR5Solution structure of Serine 65 phosphorylated UBL domain from parkinsolution nmrA——
5TR5Solution structure of serine 65 phosphorylated ubl domain from parkinsolution nmrA——
6GLCStructure of phospho-Parkin bound to phospho-ubiquitinx-ray diffractionAZN—
6GLCStructure of phospho-parkin bound to phospho-ubiquitinx-ray diffractionA3CN, ZN—
6HUEParkinS65Nx-ray diffractionA, BZN, SO4, CL—
6HUEPARKINS65Nx-ray diffractionA, BZN, SO4, CL—
6N13UbcH7-Ub Complex with R0RBR Parkin and phosphoubiquitinsolution nmrBZN9 (best 0.75)
6N13UBCH7-ub complex with R0RBR parkin and phosphoubiquitinsolution nmrBZN—
8IK6pUbl depleted Parkin complex with pUbiquitinx-ray diffractionC, AZN, SO45 (best 0.75)
8IKMTrans complex of phospho parkinx-ray diffractionA, CZN3 (best 0.71)
8IKTTernary trans-complex of phospho-parkin with cis ACT and pUbx-ray diffractionA, CZN, 3CN2 (best 0.73)
8IKVpUbl depleted phospho-Parkin(K211N,R163D) in complex with pUbx-ray diffractionC, AZN7 (best 0.67)
8JWVUntethered R0RBRx-ray diffractionAZN2 (best 0.54)
8WZNParkinK211N in complex with phospho NEDD8x-ray diffractionAZN4 (best 0.61)
8WZOParkin in complex with phospho NEDD8x-ray diffractionAZN4 (best 0.66)
O60260AlphaFold monomer V2.0 prediction for E3 ubiquitin-protein ligase parkin (O60260)predictedA—10 (best 0.62)

Ligands

  • ZN · Zinc ion · in 19 records
  • CL · Chloride ion · in 7 records
  • SO4 · Sulfate ion · in 5 records
  • 3CN · 3-aminopropane · in 4 records
  • TMO · trimethylamine oxide · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.